Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • BW TV
  • Subscribe to Print

Latest Articles in ajanta pharma

Ajanta Pharma Q1 Profit Up 29% At Rs 148 Cr

Revenue from operations surged to Rs 668.20 crore during the quarter under review from Rs 611.94 crore in the same period of 2019-20.

Read More

Ajanta Employees Raised Rs.1 Cr. To Battle Covid-19

In the fight against Covid-19 over 6,300 Ajanta employees from Maharashtra expressed their solidarity with the government by voluntarily contributed Rs. 1 cr. from their salaries.

Read More

Where Clarity Is A Prime Concern

Some unorganised players in the industry could suffer

Read More

A Classic Turnaround Story

The Agrawal brothers of Ajanta Pharma — Yogesh and Rajesh could achieve this 360 degree turn around of the family business, which was saddled with huge debt and declining growth, in the last 10 years

Read More

Ajanta Pharma Gets USFDA Nod For Generic Acid Reflux Drug

The product is a generic version of Santarus Inc’s Zegerid powder for oral suspension, Ajanta Pharma says

Read More

Ajanta Pharma Gets USFDA Approval Of Zolmitriptan Tablets

USFDA has granted Ajanta Pharma 9 ANDA final approvals and two tentative approvals. Additional 15 ANDAs are under review with the American regulator

Read More

Ajanta Pharma: Turn Around Man

A rank holder in the 1984 batch of the Institute of Chartered Accountants, Agrawal started his career with IDBI, then one of the leading financial institutions in the country.

Read More

Ajanta Pharma: A Dose Of Strong Medicine

Lacking the financial or operational muscle to compete with pharma giants, Ajanta focused on first-of-its-kind drugs to script a turnaround

Read More